Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 1147 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Leibowitz M, Karpati T, Cohen-Stavi CJ, Feldman BS, Hoshen M, Bitterman H, Suissa S, Balicer RD. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic heart disease taking statin treatment. JAMA Intern Med 2016;176:1105-13. [Ref.ID 100700]
2. Cita con resumen
Anónimo. Trimetazidina: se recuerda que actualmente su única indicación autorizada es el tratamiento de la angina de pecho . Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2016:19 de julio. [Ref.ID 100502]
3. Cita con resumen
Ohman EM. Chronic stable angina. N Engl J Med 2016;374:1167-76. [Ref.ID 100166]
4. Cita con resumen
Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B, After Eighty study investigators. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet 2016;387:1057-65. [Ref.ID 100152]
5.Tiene citas relacionadas Cita con resumen
Weisz G, Généreux P, Iniguez A, Zurakowski A, Shechter M, Alexander KP, Dressler O, Osmukhina A, James S, Ohman EM, Ben-Yehuda O, Farzaneh-Far R, Stone GW, for the RIVER-PCI Investigators. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2016;387:136-45. [Ref.ID 100087]
6.Tiene citas relacionadas
Head SJ, Kappetein AP. Coronary artery disease: a dam in the river for ranolazine. Lancet 2016;387:100-2. [Ref.ID 100085]
7. Cita con resumen
Pfeffer MA, Clagget B, Diaz R, Dickstein K, Gerstein HC, Kober LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, ELIXA Investigators. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 2015;373:2247-57. [Ref.ID 99794]
8.Enlace a cita original Cita con resumen
Kivimäki M, Jokela M, Nyberg ST, Singh-Manoux A, Fransson EI, Alfredsson L, Bjorner JB, Borritz M, Burr H, Casini A, Clays E, De Bacquer D, Dragano N, Erbel R, Geuskens GA, Hamer M, Hooftman WE, Houtman IL, Jöckel K-H, Kittel F, Knutsson A, Koskenvuo M, Lunau T, Madsen IEH, Nielsen ML, Nordin M, Oksanen T, Pejtersen JH, Pentti J, Rugulies R, Salo P, Shipley MJ, Siegrist J, Steptoe A, Suominen SB, Theorell T, Vahtera J, Westerholm PJM, Westerlund H, O'Reilly D, Kumari M, Batty GD, Ferrie JE, Virtanen M, IPD-Work Consortium. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals. Lancet 2015;386:1739-46. [Ref.ID 99622]
9. Cita con resumen
Anónimo. Ivabradine (Corlanor) for heart failure. Med Lett Drugs Ther 2015;57:75-6. [Ref.ID 99451]
10. Cita con resumen
Anónimo. Antithrombotic drugs. Med Lett Drugs Ther 2014;56:103-8. [Ref.ID 98343]
13. Cita con resumen
Schufelt CL, Merz CN, Prentice RL, Pettinger MB, Rossouw JE, Aroda VR, Kaunitz AM, Lakshminarayan K, Martin LW, Phillips LS, Manson JE. Hormone therapy and cardiovascular disease risk: dose, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause 2014;21:260-6. [Ref.ID 97430]
14. Cita con resumen
Comte H, Auffret M, Lelièvre B, Béné J, Steen P, Gautier S. Tachycardie et douleurs précordiales sous agomélatine: à propos d'un cas. Therapie 2013;68:324-5. [Ref.ID 96645]
15.
Jones DA, Timmis A, Wragg A. Novel drugs for treating angina. BMJ 2013;347:34-7. [Ref.ID 96409]
17. Cita con resumen
Anónimo. FDA approves antisense therapy for HoFH. DIA Daily 2013:31 de enero. [Ref.ID 94643]
20.Tiene citas relacionadas
Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet 2012;380:601-10. [Ref.ID 93579]
Seleccionar todas
 
 1 a 20 de 1147 siguiente >>